Comparing 2 hypotheses side-by-side
Activity-dependent tau release occurs via SNARE-dependent synaptic vesicle fusion. SNAP-25 (not SNAP-23 as originally proposed), VAMP2, and synaptotagmin-1 form the core machinery. CRISPR interference or tetanus toxin could block trans-synaptic tau efflux, but specificity remains challenging due to pleiotropic functions of SNARE components.
**Molecular Mechanism and Rationale** The synaptic vesicle tau capture inhibition hypothesis centers on the critical role of SNAP25 (Synaptosome-Associated Protein of 25 kDa) in facilitating pathological tau protein uptake at presynaptic terminals during synaptic vesicle recycling processes. SNAP25 is a key component of the SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment protein REceptor) complex, which mediates synaptic vesicle fusion with the presynaptic membrane during neurotrans
| Dimension | Targeting Synaptic Vesicle Rel | Synaptic Vesicle Tau Capture I |
|---|---|---|
| Mechanistic | 0.520 | 0.360 |
| Evidence | 0.650 | 0.342 |
| Novelty | 0.620 | 0.357 |
| Feasibility | 0.580 | 0.323 |
| Impact | 0.680 | 0.347 |
| Druggability | 0.700 | 0.350 |
| Safety | 0.450 | 0.000 |
| Competition | 0.720 | 0.000 |
| Data | 0.800 | 0.000 |
| Reproducible | 0.600 | 0.000 |
No evidence citations yet
No evidence citations yet
4 rounds · quality: 0.78
# Mechanistic and Therapeutic Hypotheses: Trans-synaptic Tau Propagation in Alzheimer's Disease --- ## Hypothesis 1: Targeting Synaptic Vesicle Release Machinery to Block Tau Exocytosis **Mechanism...
# Critical Evaluation of Tau Propagation Hypotheses ## Hypothesis 1: Synaptic Vesicle Release Machinery Blockade ### Weak Links - **Molecular target confusion**: The hypothesis conflates SNAP-23 wit...
# Feasibility Assessment: Trans-Synaptic Tau Propagation Mechanisms in Alzheimer's Disease ## Executive Summary Following rigorous critical evaluation, three hypotheses merit substantive feasibility...
{ "ranked_hypotheses": [ { "title": "Enhancing Microglial Phagocytosis of Extracellular Tau via TREM2 Activation", "description": "TREM2 agonism promotes microglial clearance of extr...
Curated mechanism pathway diagrams from expert analysis
graph TD
A["Pathological Tau<br/>Oligomers"]
B["SNAP25<br/>Linker Domain"]
C["SNARE Complex<br/>Formation"]
D["Syntaxin-1A"]
E["VAMP2"]
F["Synaptic Vesicle<br/>Endocytosis"]
G["Tau-SNAP25<br/>Binding"]
H["SNARE Complex<br/>Disruption"]
I["Vesicle Recycling<br/>Impairment"]
J["Neurotransmitter<br/>Release Defects"]
K["Synaptic<br/>Dysfunction"]
L["Cognitive<br/>Decline"]
M["SNAP25<br/>Inhibitors"]
N["Tau Aggregation<br/>Prevention"]
A -->|"pathological binding"| B
B --> C
C --> D
C --> E
D --> F
E --> F
A --> G
B --> G
G -->|"complex destabilization"| H
H -->|"impaired recycling"| I
F -->|"normal process"| I
I -->|"reduced release"| J
J -->|"synaptic failure"| K
K -->|"neurodegeneration"| L
M -->|"therapeutic intervention"| G
N -->|"prevention strategy"| A
classDef normal fill:#4fc3f7
classDef therapeutic fill:#81c784
classDef pathology fill:#ef5350
classDef outcomes fill:#ffd54f
classDef molecular fill:#ce93d8
class D,E,F,C normal
class M,N therapeutic
class A,G,H,I,J,K pathology
class L outcomes
class B molecular